APA (7th ed.) Citation

Long, J., Xie, S., Zhang, W., Dou, W., Wang, Y., Wang, R., . . . Xu, Z. The nuclear factor-κ B inhibitor SN50 enhances the efficacy of B-cell maturation antigen-targeted chimeric antigen receptor T-cell therapy. Ferrata Storti Foundation.

Chicago Style (17th ed.) Citation

Long, Jinlan, Shufeng Xie, Wenjie Zhang, Weiyu Dou, Yixin Wang, Ruiheng Wang, Han Liu, and Zhenshu Xu. The Nuclear Factor-κ B Inhibitor SN50 Enhances the Efficacy of B-cell Maturation Antigen-targeted Chimeric Antigen Receptor T-cell Therapy. Ferrata Storti Foundation.

MLA (9th ed.) Citation

Long, Jinlan, et al. The Nuclear Factor-κ B Inhibitor SN50 Enhances the Efficacy of B-cell Maturation Antigen-targeted Chimeric Antigen Receptor T-cell Therapy. Ferrata Storti Foundation.